RxDoctor Payments Data

Donna Davis, DO

Pain Medicine · Bluffton, SCNPI 1902812910

Payments from drug & device makers

$582in general payments, 2019–2025

Across 23 payments — averaging $25.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$172
  • Scilex Pharmaceuticals Inc.$83
  • Lundbeck LLC$73
  • Collegium Pharmaceutical, Inc.$70
  • Boston Scientific$41
  • Forte Bio-pharma LLC$33
  • plus $109 from 6 others

What the payments were for

  • Food & beverage$582100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)3$172
Scilex Pharmaceuticals Inc.5$83
Lundbeck LLC1$73
Collegium Pharmaceutical, Inc.4$70
Boston Scientific2$41
Forte Bio-pharma LLC2$33
Protega Pharmaceutials Inc1$33
AbbVie1$19
Averitas Pharma Inc.1$18
Virtus Pharmaceuticals LLC1$14
Actelion Pharmaceuticals US, Inc.1$14
GSK1$11

How this compares

$582 in reported general payments places this provider in the 25th percentile of 92 pain medicine providers in South Carolina.

See all pain medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$28,735
Medicare patients
57
Services billed
242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine80$18,457
BelbucaBuprenorphine Hcl39$17,968
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen268$5,525
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen283$4,936
ButransBuprenorphine11$3,727
Gabapentin178$1,809
Naloxone Hcl23$1,409
Pregabalin58$711
Oxycodone Hcl35$538
Tizanidine Hcl28$369
Tramadol Hcl33$318
Duloxetine Hcl33$284
Acetaminophen-CodeineAcetaminophen With Codeine19$280

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$70$17,96839 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 92 pain medicine providers in South Carolina.

Other pain medicine in Bluffton

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →